870535-37-8

Basic information

• Product Name: 1H-Indole-1-carboxylic acid, 2-[[4-(acetylmethylamino)phenoxy]methyl]-6-fluoro-, 1,1-dimethylethyl ester
• CAS NO: 870535-37-8
• Molecular Formula: C23H25FN2O4
• Molecular Weight: 412.461
• Mol File: 870535-37-8.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 1H-Indole-1-carboxylic acid, 2-[[4-(acetylmethylamino)phenoxy]methyl]-6-fluoro-, 1,1-dimethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Indole-1-carboxylic acid, 2-[[4-(acetylmethylamino)phenoxy]methyl]-6-fluoro-, 1,1-dimethylethyl ester(870535-37-8)
• EPA Substance Registry System: 1H-Indole-1-carboxylic acid, 2-[[4-(acetylmethylamino)phenoxy]methyl]-6-fluoro-, 1,1-dimethylethyl ester(870535-37-8)

Safety Data

• Hazardous Substances Data: 870535-37-8(Hazardous Substances Data)

Upstream product

• 870535-39-0 tert-butyl 6-fluoro-2-(hydroxymethyl)-1H-indole-1-carboxylate 
• 579-58-8 N-methyl-(4-acetamido)phenol 

Relevant articles and documents

TISSUE FACTOR PRODUCTION INHIBITOR

A medicament which has an activity of inhibiting production of tissue factor and comprises an LXR ligand as an active ingredient; and a medicament for treatment and/or prophylaxis of vascular restenosis following angioplasty, endarterectomy, percutaneous transluminal coronary angioplasty (PTCA) or stent implantation, or treatment and/or prophylaxis of blood coagulation diseases, diseases induced by platelet aggregation including stable or unstable angina pectoris, cardiovascular and cerebrovascular diseases including thromboembolism formation diseases accompanying diabetes, rethrombosis following thrombolysis, cerebral ischemic attack, infarction, stroke, ischemia-derived dementia, peripheral artery disease, thromboembolism formation diseases during use of an aorta-coronary artery bypass, glomerulosclerosis, renal embolism, tumor or cancer metastasis, which comprises an LXR ligand as an active ingredient.